- Raffaella Capobianco, ERBC (Italy) – Co-Chair
- Pierluigi Fant, Charles River Laboratories (France) – Co-Chair
- Singh Bhanu, Gilead (US)
- Karen Bodié, AbbVie (Germany)
- Darlene Dixon, NIEHS, NIH / NTP (US)
- Paul Germann, Merck Healthcare KgaA (Germany)
- Anna Maria Giusti, Roche (Switzerland)
- Hans Harleman, Independent Consultant (Germany)
- Richard Haworth, GlaxoSmithKline (Great Britain)
- Wolfgang Kaufmann, Independent Consultant (Germany)
- Frieke Kuper, Independent Consultant (The Netherlands)
- Bob Maronpot, Independent Consultant (US)
- Heike Marxfeld, BASF (Germany)
- Giovanni Pellegrini, Astrazeneca (Sweden)
- Alessandro Piaia, Novartis (Switzerland)
- Neus Prats Costa, IRB Barcelona (Spain)
- Stephan Schmidbauer, RBM S.p.A. (Italy)
- Alok Sharma, Covance Laboratories (US)
- Mohamed Slaoui, Sanofi (France)
- Alexandru Tabaran, University of Veterinary Medicine (Romania)
- Catherine Thirion-Delalande, Charles River Laboratories (France)
- Céline Thuilliez, Pierre Fabre (France)
- Grazyna Wieczorek, Novartis (Switzerland)
- Jérôme Abadie, Veterinary School of Nantes, Oniris (France) - Chair
- Enrico Bollo, Department of Veterinary Science, University of Torino (Italy)
- Pedro Faisca, Instituto Gilbenkian de Ciencia, Lisbon (Portugal)
- Andrea Gröne, Veterinary Medecine, University of Utrecht (The Netherlands)
- Achim Grüber, Department of Veterinary Medecine, Freie Universität Berlin (Germany)
- Anja Kipar, Vetsuisse Faculty, University of Zürich (Switzerland)
- Nikolaos Papaioannou, Faculty of Veterinary Medecine, Aristotle University of Thessaloniki (Greece)
- Laura Peña, Veterinary School, Complutense University of Madrid (Spain)
- Bartolomeo Biolatti, Department of Veterinary Science, University of Torino (Italy) – Co-Chair
- Enrico Bollo, Department of Veterinary Science, University of Torino (Italy) – Co-Chair
Via Sigismondo Trecchi, 20
26100 Cremona (CR) - Italy
+39 0372 403509
info@cuttingedgepathology.eu